Burning Rock Biotech Limited
(NASDAQ: BNR)
|
8:59 PM UTC, 01/03/25 | |||
---|---|---|---|---|
Last: $7.05 | Change: -0.34 | %Change: -4.60% | Volume: 4,114 |
Open: | $ 7.29 | Volume: | 4,114 | |
---|---|---|---|---|
High: | $ 7.29 | Yield(%) | 0.00 | |
Low: | $ 7.05 | P/E Ratio (ttm): | n/a | |
Dividend ($): | n/a | Market Cap ($): | 60.84M | |
EPS ($) | -5.78 | Shares Out: | 8.23M |
% Price Change (last 4 weeks): | 6.33 |
---|---|
% Price Change (last 13 weeks): | 106.42 |
% Price Change (last 26 weeks): | 19.58 |
% Price Change (last 52 weeks): | -23.02 |
% Price Change (year to date): | 9.48 |
Return on Equity (%): | -67.11 |
---|---|
Return on Assets (%): | -49.21 |
Return on Invested Capital (%): | -47.71 |
Gross Profit Margin (%): | 67.59 |
---|---|
Net Profit Margin (%): | -121.63 |
Operating Profit Margin (%): | -124.54 |
50-day Moving Average: | $5.05 |
---|---|
200-day Moving Average: | $5.62 |
Avg. Daily Vol. (last 50 days): | 15,937 |
Avg. Daily Vol. (last 200 days): | 14,774 |
52-wk high: | $9.99 |
52-wk low: | $2.62 |
Bid: | $7.05 |
Ask: | $7.40 |
Burning Rock Biotech Ltd. engages in the investment of medical fields. It specializes in next-generation sequencing diagnostics solutions for precision medicine in oncology. The firm operates through the following segments: Central Laboratory Business, In-Hospital Business and Pharma Research and Development Services. Its products and clinical applications include companion diagnostics for targeted therapy and immunotherapy, benign, malignant tumor diagnosis, minimal residual disease monitoring, tumor recurrence and progression prediction and tumor susceptibility tests. The company was founded by Yu Sheng Han in January 2014 and is headquartered in Guangzhou, China.
|
Burning Rock Biotech Limited
No 5 Xingdao Ring Road North International Bio Island Guangzhou GD 510005 Phone: 86.20.34037871 Fax: 86.20.34037872 http://www.brbiotech.com |
Earnings (1year) ($): | -5.78 |
---|---|
Annual Dividend ($): | 0.00 |
Current P/E Ratio (ttm): | n/a |
Book Value ($): | 10.58 |
Cash Flow ($): | -8.63 |
Price/Earnings (x): | n/a |
---|---|
Price/Sales (x): | 1.26 |
Price/Book (x): | 0.88 |
Price/Cash Flow (x): | n/a |
Quick Ratio (x): | 3.09 |
---|---|
Current Ratio (x): | 3.36 |
LT Debt/Equity (x): | 0.48 |
Total Debt/Equity (x): | 1.60 |